SRSF1 and small cell lung carcinoma: SRSF1 siRNA was transfected into DMS114, and the growth effect of SRSF1 ablation in two dimensional cell culture either alone or in conjunction with a sub-lethal dose of cisplatin or topotecan (two of the most common standard of care treatments in SCLC), was evaluated (Fig 4A).